key: cord-0885100-u6nsjt9h
authors: Upadhyay, Vaibhav; Patrick, Casey; Lucas, Alexandra; Mallela, Krishna M.G.
title: SARS-CoV-2 comes up with a perfect recipe for disaster: Each mutation plays a specific role in the evolution of variants of concern
date: 2021-12-25
journal: bioRxiv
DOI: 10.1101/2021.12.23.474050
sha: 8440b106be5250367467c507c9f9c3a13563368d
doc_id: 885100
cord_uid: u6nsjt9h

COVID-19 pandemic has extended for close to two years with the continuous emergence of new variants. Mutations in the receptor binding domain (RBD) are of prime importance in dictating the SARS-CoV-2 spike protein function. By studying a series of single, double and triple RBD mutants, we have delineated the individual and collective effects of RBD mutations in a variant of concern (VOC) containing multiple mutations (Gamma variant; K417T/E484K/N501Y) on binding to angiotensin converting enzyme 2 (ACE2) receptor, antibody escape and protein stability. Our results show that each mutation in the VOC serves a distinct function that improves virus fitness landscape supporting its positive selection, even though individual mutations have deleterious effects that make them prone to negative selection. K417T contributes to increased expression, increased stability and escape from class 1 antibodies; however, it has decreased ACE2 binding. E484K contributes to escape from class 2 antibodies; however, it has decreased expression, decreased stability, and decreased ACE2 binding affinity. N501Y increases receptor binding affinity; however, it has decreased stability and decreased expression. But when these mutations come together, the deleterious effects are mitigated in the triple mutant due to the presence of compensatory effects, which improves the chances of selection of mutations together. These results show the implications of presence of multiple mutations on virus evolution and indicate the emergence of future SARS-CoV-2 variants with multiple mutations that enhance viral fitness on different fronts by balancing both positive and negative selection.

SARS-CoV-2 pandemic has disrupted the lives of millions of people around the globe for the past 2 years with enormous damage to human life and world economy. Till November 2021, the virus has infected more than 275 million people and claimed about 5 million lives (https://covid19.who.int/). The emergence of the virus variants has contributed to prolonged pandemic even after the brilliant efforts by scientific community in coming up with effective vaccines, therapeutic antibodies and antivirals within a year of the pandemic.(1-10) Emergence of the variants has caused waves of infection throughout the world, with each wave majorly contributed by a particular variant. Some of the variants are more dangerous than others and have been termed as the variants of concern (VOC). Till date, five variants have been designated as VOCs by WHO (https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/). Apart from these, numerous other variants have emerged in different parts of the world, some of which have been termed as variants of interest. These variants have raised concerns as the recent data has shown decreased efficacy of vaccines and therapeutic antibodies particularly against VOCs. (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) New vaccines and therapeutics will be needed to counter the threats posed by variants. It is thus necessary to understand the properties of the viral variants to be able to come up with more informed approaches for vaccine and therapeutics design.

Among the mutations in the viral genome, the mutations in the receptor binding domain (RBD) are of particular interest as RBD is immunodominant and target of major neutralizing antibody response against the virus.(22) Also, RBD is functionally important as it allows virus to interact with ACE2 receptor on human epithelial cells. (23) (24) (25) Thus, RBD mutations are likely to impact the antibody escape potential and ACE2 interaction, thereby influencing virus infectivity and transmission. All of the VOCs, other than Alpha, contain multiple RBD mutations. Presence of multiple RBD mutations can allow virus to acquire advantageous traits which would otherwise not be selected in the case of a single mutation. For instance, a beneficial mutation in terms of antibody escape can have deleterious effect on protein stability or ACE2 binding thereby compromising virus fitness. Such a mutation would not be strongly selected, but in the presence of a compensatory mutation that can improve stability or ACE2 binding, the otherwise deleterious mutation that confers antibody resistance would be strongly selected. Thus, the variants that contain multiple RBD mutations pose a greater threat as they are likely to have greater fitness and better adapted to survive in the host. This makes it important to study the 4 evolution of viral variants that contain multiple RBD mutations and delineate the role of each mutation in the selection of that variant.

The Gamma variant provides a perfect example of an evolved variant that contains multiple RBD mutations-K417T, E484K and N501Y. The Gamma variant was designated as an VOC and spread to many countries affecting millions of people. (26) (27) (28) (29) The three mutations in the Gamma variant RBD are in the protein structural regions that interact with ACE2 and also with major neutralizing antibodies. These mutations are thus likely to impact ACE2 binding as well as antibody binding interactions. In this study, we examined the individual and collective effect of the three RBD mutations in the Gamma variant on expression, protein stability, ACE2 binding and immune escape potential against the common neutralizing antibodies. To achieve this, we created single, double and triple mutants of RBD corresponding to the Gamma variant.

This approach would allow to determine which mutations offer improved viral fitness with respect to a particular physical parameter, and if there is an association between mutations, synergistic or antagonistic, that determines the selection of mutations together.

Gamma variant contains three RBD mutations K417T, E484K and N501Y. To understand the effects of these mutations on expression, stability, ACE2 binding and antibody escape, we created different RBD mutants comprising of single mutations (K417T, E484K, N501Y), double mutations (K417T/E484K, K417T/N501Y, E484K /N501Y) and triple mutations (K417T/E484K/N501Y). The unmutated, wild-type (WT) RBD and the seven RBD mutants corresponding to the Gamma variant were expressed in Expi293 cells which are modified human embryonic kidney (HEK) cells. These proteins were expressed as secretory proteins, which means they traverse through the secretory pathway in human cells and are subject to the endoplasmic reticulum (ER) quality control, which allows well folded proteins to secrete out of the cells while the misfolded and aggregation prone proteins are recognized and degraded through the ER degradation pathway. The protein expression levels can impact the overall virus yield as higher protein expression means greater viral packaging efficiency. (30) The mutations were found to affect the levels of protein that was secreted out of the cells (Figure 1 ). K417T mutation increased the levels of secretory protein by 70% relative to the WT protein, while E484K mutation decreased the expression level by 60%. N501Y mutation also decreased the 5 expression by 20%. The effect of these mutations was additive in the case of double mutants (with K417T mutation) and the triple mutant studied. Mutants that carried K417T mutation also had higher expression. K417T/N501Y increased expression by 40%, whereas K417T/E484K and K417T/E484K/N501Y increased expression by 10%. The presence of two deleterious mutations E484K and N501Y together had a negative cooperative effect on the expression of the double mutant E484K/N501Y, which had 80% less expression and could not be purified in high yield.

Further studies were therefore done on the WT protein and six mutant proteins excluding the double mutant E484K/N501Y. All proteins used for further studies were purified to homogeneity ( Figure 2A ). These protein expression results suggest that K417T may provide fitness advantage to the virus by providing more protein for virus assembly and thereby increasing virus transmission. It should be noted however that this study only examined the expression levels of RBD mutants, and in natural scenario, similar mutation effects on the expression of the complete spike protein and other viral proteins will determine the virus yield and infectivity.

None of the three RBD mutations affect the global protein structure. Most point mutations in proteins that have been characterized are in general neutral and do not bring a significant change to protein structure. Other mutations may be deleterious or bring an advantage to the organismal fitness. The deleterious mutations are generally not selected unless a selection pressure like immune response acts on them. Advantageous mutations on the other hand are selected. We investigated the effect of Gamma variant mutations on the secondary and tertiary structure of RBD using circular dichroism (CD) and fluorescence spectroscopy to determine if any of the mutations affect the global protein structure ( Figures 2B and 2C ). The results suggest that the global secondary as well as tertiary structure is not affected by the mutations, even though the three mutations are non-conservative where K417T mutation changes a charged amino acid to an uncharged amino acid, E484K changes a negatively charged amino acid to a positively charged amino acid, and N501Y changes a polar amino acid to an aromatic amino acid.

K417T mutation stabilizes RBD while E484K mutation destabilizes RBD. Protein stability is an important parameter that impacts the evolution of viral proteins.(31) More stable proteins can withstand higher number of deleterious mutations and thus tend to persist for longer time in the viral pool. (32) We measured the stability of the WT and mutated RBDs using thermal and chemical denaturation melts. The thermal denaturation melts were recorded using far-UV 6 CD spectroscopy. Figures 3A-3G show the representative melts. Thermal melts of RBD were not completely reversible and are thus not indicative of the equilibrium thermodynamic stability of the proteins. Therefore, thermal melts can only be used to compare the mid-point of thermal denaturation (Tm) and are good measure of apparent stability of proteins. (33) (Table 1) .

To obtain the true equilibrium thermodynamic stability of WT and mutant RBDs, chemical denaturation with urea was performed. The chemical denaturation melts were recorded using fluorescence spectroscopy. Chemical denaturation melts using CD were not used to calculate the stability of the proteins as the data was noisy below 220 nm in the presence of high concentrations of urea. β-sheet and random coil structures show maximum CD below 220 nm, and RBD is mainly composed of these secondary structures. (34) Figures 4A-4G show representative urea denaturation melts, and Table 2 lists the fit parameters determined from three independent batches of protein expression. The chemical denaturation of RBD in urea using fluorescence was found to be completely reversible. The free energy change on unfolding (∆Gunf) for the WT RBD was 8.1 ± 0.3 kcal/mol. Like the thermal denaturation melts, K417T mutation was found to stabilize and E484K mutation was found to destabilize RBD with ∆Gunf values of 9.8 ± 0.3 and 7.0 ± 0.2 kcal/mol respectively. N501Y mutation was also found to destabilize RBD with a ∆Gunf value of 7.1 ± 0.2 kcal/mol. The double mutants that carried K417T mutation were more stable than the WT protein, with ∆Gunf values of 8.7 ± 0.2 and 8.4 ± 0.2 kcal/mol for K417T/E484K and K417T/N501Y mutants, respectively. The triple mutant on the other hand had the least stability with ∆Gunf value of 6.7 ± 0.2 kcal/mol, possibly showing the cooperative effect of two deleterious mutations E484K and N501Y on protein stability. N501Y mutation enhances binding affinity towards ACE2. SARS-CoV-2 relies on the binding of RBD to ACE2 receptor on the host cells to enter the host and is thus an important parameter that determines virus infectivity and transmission. The RBD mutations that increase the binding affinity towards ACE2 have a selective advantage and can naturally be selected during virus evolution. To determine which of the mutations in the Gamma variant provide the virus with selective advantage for improved ACE2 binding, binding affinity of the RBD mutants towards ACE2 was determined using isothermal titration calorimetry (ITC) and compared it with the binding affinity of WT RBD. Figures 5A-5G show representative ITC thermograms, and Table 3 lists the average fit parameters from three independent batches of protein expression. ITC thermograms for some of the high affinity variants leading to a fewer points in the binding transition, which is also reflected in the experimental errors, the Kd values clearly support our conclusions on ACE2 binding. This is also true for the conclusions drawn below from ITC thermograms for antibody binding.

K417T mutation determines escape from class 1 antibodies. The escape from neutralizing antibodies is one of the major factors that govern the natural selection of variants.

The host antibody response towards the SARS-CoV-2 is varied with different antibodies produced against a range of viral epitopes, out of which only a few are neutralizing. RBD is the major target against which neutralizing antibodies are produced. (22, (35) (36) (37) These neutralizing antibodies can be divided into different classes based on their site of interaction with RBD and consequently the mechanism of neutralization. (22, 35) Majorly, two classes of antibodies (class 1 and class 2) bind to the site on RBD which is also the site of interaction with ACE2. Apart from that, class 3 antibodies also share some region of the binding site with ACE2 ( Figure Table 4 lists the average parameters obtained from three independent batches of protein expression. CC12.1 interacts with WT RBD with Kd value of 23.9 ± 5.7 nM. Out of the single site mutants, K417T decreased the binding affinity substantially with a Kd value of 301 ± 52 nM. The other single site mutants E484K and N501Y did not show escape from CC12.1 binding with Kd values of 1.7 ± 4.6 nM and 53.7 ± 12.1 nM respectively. All the other double and triple mutants that carried the K417T mutation also showed escape from CC12.1 binding with higher Kd values (429 ± 266 nM, 553 ± 273 nM and 402 ± 29 nM for K417T/E484K, K417T/N501Y and K417T/E484K/N501Y respectively). These results suggest that the escape of Gamma variant from class 1 antibodies is conferred predominantly by the K417T mutation.

E484K mutation determines escape from class 2 antibodies. Class 2 antibodies differ from class 1 antibodies in the mode of interaction with RBD ( Figure 6 ). Their epitope differs from that of class 1 antibodies, and they can recognize RBD in both up and down conformation.

One advantage of class 2 antibodies is that they can recognize adjacent RBDs in the spike trimer and once bound they can lock RBDs in down conformation thereby restricting binding to ACE2. (39) This difference in the mode of interaction with RBD is thought to be because of longer H3 CDR in class 2 antibodies compared to class 1 antibodies. LY-CoV555 antibody is a class 2 antibody which was part of the Eli Lilly's antibody cocktail authorized for emergency use in USA by FDA. (40) We have used LY-CoV555 as a representative example of class 2 antibodies and determined its binding to WT and mutant RBDs. Figures 8A-8G show representative thermograms, and Table 5 Table 6 lists the average fit parameters obtained from three independent batches of protein expression. These results indicate that the Gamma variant and its constituent mutations do not escape class 3 antibodies, and REGN-10987 will still be able to neutralize the Gamma variant.

The continued emergence of variants over a small timeframe means adaptive evolution of virus in the human host. K417T and K417N mutations rank 4 th and 6 th respectively on the list of mutations in RBD with highest frequency of occurrence (https://www.gisaid.org/hcov19-mutation-dashboard/) and are also part of the two VOCs Gamma and Beta, respectively. Change of residue from lysine to threonine has a penalty on the ACE2 binding affinity, which is not surprising as lysine residue provides a beneficial effect towards ACE2 binding. This means that the improved ACE2 binding is not a parameter which supports the positive selection of K417T mutation. The beneficial effect of K417T mutation is however seen in all the other aspects we examined. K417T mutation improved the expression of RBD and this effect was also observed for double mutants and the triple mutant carrying K417T mutation. K417T also increased the stability of RBD relative to the WT protein. It stabilized RBD by about 2 kcal/mol in chemical denaturation experiments (Table   2 ). Thermal denaturation melts also showed substantial increase in Tm by about 3°C (Table 1) (Figures 3 and 4) . As protein stability is an important factor that determines the inclusion of other mutations and also the persistence of mutations in viral lineages, a mutation that destabilizes the protein must have a strong reason for its so widespread and common selection in multiple lineages, which is provided by the antibody escape potential of E484K. Our results show that E484K escapes LYCoV-555, a class 2 antibody. Amongst the three Gammavariant RBD mutations, only E484K lies on the interaction surface of LYCoV-555 ( Figure 10B ).

The binding of WT RBD to LY-CoV555 antibody is substantially strengthened by the interaction of E484 with two arginine residues, R50 in the heavy chain and R96 in the light chain variable regions of LY-CoV555. E484K mutation is a non-conservative mutation and change to an oppositely charged lysine residue disrupts these electrostatic interactions and contributes to antibody escape. The importance of E484K mutation has been further highlighted by the observation that escape from class 2 antibodies mainly contributes to escape from polyclonal plasma.(57) These arguments present strong evidence for the positive selection of E484K mutation, and its convergent evolution conferred by its ability to escape neutralizing antibodies despite the penalty levied by decreased stability and expression. In the Gamma variant, the simultaneous presence of K417T mutation appears to mitigate the negative effects on stability and expression. The double mutant (K417T/E484K) and the triple mutant (K417T/E484K/N501Y) have expression levels comparable to that of the wild-type RBD, and stability higher than the E484K mutant alone.

N501Y was amongst the first RBD mutations that was identified and was the only RBD mutation in the Alpha variant, the first variant to be designated as the VOC.(58, 59) Shortly after, Beta and Gamma variants emerged in different parts of the world, carrying N501Y mutation and were also designated as VOCs. (26, 60) N501Y is the 2 nd most frequently found mutation according to GISAID and points towards its positive selection. N501Y has been shown to improve the binding affinity towards ACE2 by us and other groups, (34, 55, (61) (62) (63) (64) and it is now established that the N501Y mutation increases the transmissibility and infectivity of the virus providing a selective advantage to virus fitness leading to its natural selection. with averaging time of 2 s was plotted against temperature to obtain the denaturation curve. The data were fit to a two-state unfolding model using the equation(33)

Where ST is the measured ellipticity signal with respect to temperature T, SN and SU are the Protein stability was measured using fluorescence spectroscopy following urea denaturation. Fluorescence intensity at 320 nm obtained at varying urea concentrations is represented as black circles. The fits passing through the data points are represented as red lines. Multiple mutations selected together Figure 11 . Each mutation in VOCs serves a distinct function that improves virus fitness even though individually each mutation has deleterious effects. When the mutations come together, the deleterious effects are mitigated due to the presence of compensatory effects.

Maintaining Safety with SARS-CoV-2 Vaccines

An EUA for sotrovimab for treatment of COVID-19

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail

An mRNA Vaccine against SARS-CoV-2 -Preliminary Report

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus

Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK

Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil

Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan

Mechanisms of virus assembly

Evolution on the Biophysical Fitness Landscape of an RNA Virus

Stability of the Influenza Virus Hemagglutinin Protein Correlates with Evolutionary Dynamics

Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions

Receptor binding, immune escape, and protein stability direct the natural selection of SARS-CoV-2 variants

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

Structural basis of a shared antibody response to SARS-CoV-2

An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Ongoing global and regional adaptive evolution of SARS-CoV-2

Are Convergent and Parallel Amino Acid Substitutions in Protein Evolution More Prevalent Than Neutral Expectations?

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Evolution of antibody immunity to SARS-CoV-2

SARS-CoV-2 variants, spike mutations and immune escape

SARS-CoV-2 evolution during treatment of chronic infection

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Protein stability promotes evolvability

A biophysical protein folding model accounts for most mutational fitness effects in viruses

Stability-mediated epistasis constrains the evolution of an influenza protein

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

The biological and clinical significance of emerging SARS-CoV-2 variants

Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics

Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Detection of a SARS-CoV-2 variant of concern in South Africa

The basis of a more contagious 501Y.V1 variant of SARS-CoV-2

N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants

N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2

The N501Y spike substitution enhances SARS-CoV-2 infection and transmission

Data Reduction and Error Analysis for the Physical Sciences

Determination and analysis of urea and guanidine hydrochloride denaturation curves

Unfolding Free-Energy Changes Determined by the Linear Extrapolation Method .1. Unfolding of Phenylmethanesulfonyl Alpha-Chymotrypsin Using Different Denaturants